178 related articles for article (PubMed ID: 32227540)
1. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake.
Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D
Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540
[TBL] [Abstract][Full Text] [Related]
2. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
4. High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging α
Piras M; Testa A; Fleming IN; Dall'Angelo S; Andriu A; Menta S; Mori M; Brown GD; Forster D; Williams KJ; Zanda M
ChemMedChem; 2017 Jul; 12(14):1142-1151. PubMed ID: 28608961
[TBL] [Abstract][Full Text] [Related]
5. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
[TBL] [Abstract][Full Text] [Related]
6. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
Sani S; Messe M; Fuchs Q; Pierrevelcin M; Laquerriere P; Entz-Werle N; Reita D; Etienne-Selloum N; Bruban V; Choulier L; Martin S; Dontenwill M
Chembiochem; 2021 Apr; 22(7):1151-1160. PubMed ID: 33140906
[TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
8. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
Paulus J; Nachtigall B; Meyer P; Sewald N
Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
10. Interaction Mechanism and Clustering among RGD Peptides and Integrins.
Dong X; Yu Y; Wang Q; Xi Y; Liu Y
Mol Inform; 2017 May; 36(5-6):. PubMed ID: 28004516
[TBL] [Abstract][Full Text] [Related]
11. Shifting Towards α
Bugatti K; Bruno A; Arosio D; Sartori A; Curti C; Augustijn L; Zanardi F; Battistini L
Chemistry; 2020 Oct; 26(59):13468-13475. PubMed ID: 32634263
[TBL] [Abstract][Full Text] [Related]
12. alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers.
Rerat V; Dive G; Cordi AA; Tucker GC; Bareille R; Amédée J; Bordenave L; Marchand-Brynaert J
J Med Chem; 2009 Nov; 52(22):7029-43. PubMed ID: 19860432
[TBL] [Abstract][Full Text] [Related]
13. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
14. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
[TBL] [Abstract][Full Text] [Related]
16. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
[TBL] [Abstract][Full Text] [Related]
17. Tumor Targeting with an isoDGR-Drug Conjugate.
Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
[TBL] [Abstract][Full Text] [Related]
18. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
[TBL] [Abstract][Full Text] [Related]
19. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
[TBL] [Abstract][Full Text] [Related]
20. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
Dal Corso A; Pignataro L; Belvisi L; Gennari C
Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
